Miriam Merad MD, PhD

Miriam Merad, M.D.; Ph.D. is a Professor of the Department of Oncological Sciences and the Department of Medicine (Hem/Onc division) and a Member of the Immunology Institute and The Tisch Cancer Institute at the Mount Sinai School of Medicine in New York. Dr. Merad obtained her MD at the University of Algiers, Algeria. She did her residency (Internat des hopitaux) in Hematology and Oncology in Paris, France and obtained her PhD in immunology in collaboration between Stanford University and University of Paris VII. She was recruited at the Mount Sinai School of Medicine in 2004 and was promoted to the rank of Professor with Tenure in 2010. She also serves as the program leader of the Cancer immunology immunotherapy group at The Tisch Cancer Institute and as an Assistant Director for the MD PhD program at Mount Sinai. Her laboratory studies the mechanisms that control dendritic cells and macrophages development and function in disease. Dr. Merad also studies the role of the host hematopoietic compartment in allogeneic hematopoietic cell transplantation and she has launched the dendritic cell-based vaccine program in allogeneic hematopoietic cell transplantation at Mount Sinai.